Skip to main content

 Related scientific articles (all)

Right ventricular longitudinal fractional shortening: a substitute to right ventricular free wall longitudinal strain?

Authors : Unger P, Paesmans M, Vachiery JL, Rietz M, Amzulescu M, David-Cojocariu A
Year : 2022
Journal : Heart Vessels
Volume : 37
Pages : 426-433

Prediction of an Imminent Fracture After an Index Fracture - Models Derived From the Frisbee Cohort.

Authors : Iconaru L, Charles A, Baleanu F, Surquin M, Benoit F, Mugisha A, Moreau M, Paesmans M, Karmali R, Rubinstein M, Rozenberg S, Body JJ, Bergmann P
Year : 2022
Journal : J Bone Miner Res
Volume : 37
Pages : 59-67

Author Correction: FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.

Authors : Gombos A, Venet D, Ameye L, Vuylsteke P, Neven P, Richard V, Duhoux FP, Laes JF, Rothe F, Sotiriou C, Paesmans M, Awada A, Guiot T, Flamen P, Piccart-Gebhart M, Ignatiadis M, Gebhart G
Year : 2022
Journal : NPJ Breast Cancer
Volume : 8
Pages : 38

Fragility fractures in postmenopausal women: development of 5-year prediction models using the FRISBEE study.

Authors : Baleanu F, Moreau M, Charles A, Iconaru L, Karmali R, Surquin M, Benoit F, Mugisha A, Paesmans M, Rubinstein M, Rozenberg S, Bergmann P, Body JJ
Year : 2022
Journal : J Clin Endocrinol Metab

Evaluation of the Comprehensive Geriatric Assessment (CGA) tool as a predictor of postoperative complications following major oncological abdominal surgery in geriatric patients.

Authors : Penning Y, El Asmar A, Moreau M, Raspé J, Dal Lago L, Pepersack T, Donckier V, Liberale G
Year : 2022
Journal : PLoS One
Volume : 17
Pages : e0264790

Correction to: Epidemiology and Outcome of Fungemia in a Cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031). CORRECTION TO Cornely OA, et al. Clin Infect Dis. 2015. PM

Authors : Cornely OA, Gachot B, Akan H, Bassetti M, Uzun O, Kibbler C, Marchetti O, de Burghgraeve P, Ramadan S, Pylkkanen L, Ameye L, Paesmans M, Donnelly JP
Year : 2022
Journal : Clin Infect Dis

Drug-related problems and risk factors related to unplanned hospital readmission among cancer patients in Belgium.

Authors : Koubaity M, Lechon AS, Amighi K, Van Nuffelen M, Moreau M, Meert AP, De Vriese C
Year : 2021
Journal : Support Care Cancer
Volume : 29
Pages : 3911-3919

Risk factors for imminent fractures: a substudy of the FRISBEE cohort.

Authors : Iconaru L, Moreau M, Baleanu F, Kinnard V, Charles A, Mugisha A, Surquin M, Benoit F, Karmali R, Paesmans M, Body JJ, Bergmann P
Year : 2021
Journal : Osteoporos Int
Volume : 32
Pages : 1093-1101

Initiation of a new anti-cancer medical treatment in ICU: a retrospective study.

Authors : Chicoisneau M, Paesmans M, Ameye L, Sculier JP, Meert AP
Year : 2021
Journal : Acta Clin Belg
Pages : 1-9

Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variants.

Authors : Lambertini M, Ceppi M, Hamy AS, Caron O, Poorvu PD, Carrasco E, Grinshpun A, Punie K, Rousset-Jablonski C, Ferrari A, Paluch-Shimon S, Toss A, Senechal C, Puglisi F, Pogoda K, Pérez-Fidalgo JA, De Marchis L, Ponzone R, Livraghi L, Estevez-Diz MDP, Villarreal-Garza C, Dieci MV, Clatot F, Duhoux FP, Graffeo R, Teixeira L, Córdoba O, Sonnenblick A, Ferreira AR, Partridge AH, Di Meglio A, Saule C, Peccatori FA, Bruzzone M, tKint de Roodenbeke MD, Ameye L, Balmaña J, Del Mastro L, Azim HA Jr
Year : 2021
Journal : NPJ Breast Cancer
Volume : 7
Pages : 16

Fortnightly or fractionated weekly docetaxel-cisplatin-5-FU as first-line treatment in advanced gastric and gastroesophageal junction adenocarcinoma: The randomized phase II DoGE study.

Authors : Deleporte A, Van den Eynde M, Forget F, Holbrechts S, Delaunoit T, Houbiers G, Kalantari HR, Laurent S, Vanderstraeten E, De Man M, Vergauwe P, Clausse M, Van Der Auwera J, DHondt L, Pierre P, Ghillemijn B, Covas A, Paesmans M, Ameye L, Awada A, Sclafani F, Hendlisz A
Year : 2021
Journal : Cancer Med
Volume : 10
Pages : 4366-4374

Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer.

Authors : Zahavi T, Salmon-Divon M, Salgado R, Elkin M, Hermano E, Rubinstein AM, Francis PA, Di Leo A, Viale G, de Azambuja E, Ameye L, Sotiriou C, Salmon A, Kravchenko-Balasha N, Sonnenblick A
Year : 2021
Journal : NPJ Breast Cancer
Volume : 7
Pages : 67

Prevalence and clinical impact of tumor BRCA1 and BRCA2 mutations in patients presenting with localized or metastatic hormone-sensitive prostate cancer.

Authors : Martinez Chanza N, Bernard B, Barthelemy P, Accarain A, Paesmans M, Desmyter L, Tkint de Roodenbeke D, Gil T, Sideris S, Roumeguere T, Hamid AA, Sweeney CJ
Year : 2021
Journal : Prostate Cancer Prostatic Dis

Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trial.

Authors : De Caluwé A, Buisseret L, Poortmans P, Van Gestel D, Salgado R, Sotiriou C, Larsimont D, Paesmans M, Craciun L, Drisis S, Vandekerckhove C, Reyal F, Veys I, Eiger D, Piccart-Gebhart M, Romano E, Ignatiadis M
Year : 2021
Journal : BMC Cancer
Volume : 21
Pages : 899

Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer.

Authors : Woff E, Salvatore L, Marmorino F, Genovesi D, Critchi G, Guiot T, Ameye L, Sclafani F, Hendlisz A, Flamen P
Year : 2021
Journal : J Nucl Med

Analyses of the Rationale and Implementation of Research Biopsies in Oncology Clinical Trials at a Tertiary Cancer Center.

Authors : Olympios N, Collet L, Paesmans M, Jungels C, Kotecki N, Awada A, Aftimos P
Year : 2021
Journal : Oncologist
Volume : 26
Pages : 1062-1070

Sepsis and Septic Shock Definitions in Patients With Cancer Admitted in ICU.

Authors : Nathan N, Sculier JP, Ameye L, Paesmans M, Grigoriu B, Meert AP
Year : 2021
Journal : J Intensive Care Med
Volume : 36
Pages : 255-261

Independent External Validation of FRAX and Garvan Fracture Risk Calculators: A Sub-Study of the FRISBEE Cohort.

Authors : Baleanu F, Iconaru L, Charles A, Kinnard V, Fils JF, Moreau M, Karmali R, Surquin M, Benoit F, Mugisha A, Paesmans M, Laurent MR, Bergmann P, Body JJ
Year : 2021
Journal : JBMR Plus
Volume : 5
Pages : e10532

FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.

Authors : Gombos A, Venet D, Ameye L, Vuylsteke P, Neven P, Richard V, Duhoux FP, Laes JF, Rothe F, Sotiriou C, Paesmans M, Awada A, Guiot T, Flamen P, Piccart-Gebhart M, Ignatiadis M, Gebhart G
Year : 2021
Journal : NPJ Breast Cancer
Volume : 7
Pages : 125

<sup>68</sup>Ga-PSMA PET/CT for response assessment and outcome prediction in metastatic prostate cancer patients treated with taxane-based chemotherapy.

Authors : Shagera QA, Artigas C, Karfis I, Critchi G, Martinez Chanza N, Sideris S, Peltier A, Paesmans M, Gil T, Flamen P
Year : 2021
Journal : J Nucl Med